A recent study emphasizes the necessity of ongoing surveillance of COVID-19 variants and vaccine effectiveness, revealing that monovalent vaccines offer higher antibody levels against Omicron variants than bivalent vaccines. However, current vaccines may not prevent transmission of the newest strains, highlighting the need for continuous vaccine updates and the development of effective antibody treatments.
Scientists at the Francis Crick Institute and the National Institute for Health and Care Research Biomedical Research Centre at University College London Hospital stress the need for ongoing monitoring of new
Published as a research letter in DOI: 10.1016/S0140-6736(24)00316-7